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Papillary Fibroelastoma: A Review of
Echocardiographic Criteria for Diagnosis with
Pathologic Correlation
Aortic Stenosis - Noninvasive Assessment of
Prognosis
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Kyle W. Klarich, Maurice E. Sarano, George M. Gura, A. Jamil Tajik, James
B. Seward. Mayo Clinic, Rochester, Minnesota
Papillary fibroelastoma (PFEI is a rare, benign cardiac tumor, diagnosis (dx)
usually made at autopsy. Consistent experience with echo analysis is not
available. With availability of high resolution echocardiography (echo). dx is
being made more frequently clinically. From 1988-1994 13 pts had patho-
logic confirmation (path) of PFE and an echo performed. Echo made the dx
of PFE in 11/13 (85%) pts. Echo analysis of these 11 pts showed the PFE
characteristics to be: relatively small tumors (mean 12.2 x 8.6 mm). homo-
geneous frond-like echodensity, usually pedunculated, attached to the en-
docardial surface, mobile, with a characteristic vibration or shimmer in the
blood flow.
A total of 47 pts had a diagnosis of PFE made by echo found in the ab-
sence of endocarditis, with a total of 54 PFE (5 pts had multiple PFE). In 25
the diagnosis was possible by transthoracic echo (TIE) and confirmed by
transesophageal (TEE) in 9. In 15 the diagnosis was uncertain by TIE and
made by TEE. In 7 only the TEE was available for diagnosis, The location
of the PFE was valvular endocardium in 48/55 (87%) (mitral 21, aortic 21,
tricuspid 5, and pulmonary 1) and nonvalvular endocardium in 6. The stalk
of attachment was seen in 36/54 (67%). Concomitant valvular disease was
seen in 17/47 pts 131 %) but usually was mild and not due to the PFE. Embolic
phenomena occurred in 8/47 pts (17%), and neurologic in 6/8.
We conclude that: (1) Echo can make a dx of PFE in a high percentage
of pts with PFE; (21 the incidence of embolism is relatively high, suggewt-
ing PFE may be a source of embolism, (3) there is an incremental value of
TEE over TIE in diagnosis; (4) most cases were incidental findings without
valvular dysfunction,
tives were younger (expected because more children and fewer parents of
MR+ probands could be evaluated). and more likely to be male. MR+ and
MR- relatives were virtually identical in regard to body habitus, blood pres-
sure, the prevalence of auscultatory findings, thoracic bony abnormalities
and palpitations and all echo measurements including anterior mitral leaflet
thickness. Four instances of significant MR and two MVP-related complica-
tions (infective endocarditis and transient ischemic attack) occurred in the
82 relatives of MR- probands as opposed to none among relatives of MR+
probands. In 20 families, one proband or relative with MVP had severe MR
and at least one other with MVP (presumably due to the same gene) was
free of MR or complications. Thus, MVP with severe MR does not represent
a heritable phenotype and commonly coexists with mild forms of MVP in the
same family, making their classification as separate conditions illogical and
potentially misleading.
Martin Kraus, Rolf Jenni, Juraj Turina. Cardiology, University Hospital, Zurich,
Switzerland
During the last 10 years (y) 97 patients (pts). mean age 52.5 y, with aortic
stenosis (AS) were regularly controlled in the out-patients clinic (mean fol-
low up 4.5 y), Throughout the follow up 16 cardiac death occured (9/16 pts
declined the operation) and 39 pts were operated. According to the Doppler
echocardiography (DE) at the beginning AS was mild in 43, moderate in 34
and severe in 20 pts. Initially 30/43 (70%) pts with mild, 12/34 (35%) with
moderate and 7/20 (35%) with severe AS were in NYHA class I. The great
majority (41/49,84%) of NYHA class I pts had normal exercise capacity, re-
gardless of AS severity. At the last visit 16/43 (37%) with initially mild had
moderate and 10/43 (23%) severe AS. 4/1 0 pts developed severe AS in the
time of 5 y, 19/34 (54%) pts with initially moderate developed severe AS. Pro-
gression in DE was in 25/45 (56%) followed by an increase in NYHA class but
in 8/33 (24%) pts worsening of NYHA class was not related to an increase in
DE. Progression to severe AS was followed by an increase in NYHA class in
20/29 (69%1 and decrease in exercise capacity in 17/29 (59%) pts; systolic
pressure did not increase or decreased with exercise in 10/29 (35%) pts. All
16 pts who died developed symptoms before death but in 2 physical activity
was not limited. 1/16 had mild and 3/16 moderate AS. These 4 pts had angina
and died sudden; coronary artery disease (CAD) was proven in 3/4 (1 pt with-
out angiography). 37/39 (95%) of pts admitted to surgery were symptomatic
but 8/39 (20%) had only moderate AS.
Conclusions: 1) within 5 y 10% of pts progress from mild to severe AS, 2)
30% of pts with severe AS were asymptomatic with a normal exercise capac-
ity, 3) increase in symptoms, decrease in work capacity and absent increase
in systolic pressure at ergometry are the best signs of stenosis progression
to severe AS, 4) the risk of sudden death in asymptomatic pts is very low
regardless of AS severity, 5) pts with angina in even mild or moderate AS are
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Uncomplicated Mitral Prolapse? Results of
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Late Results of Balloon Pulmonary Valvuloplasty
in Adults
Mohammad Ali Sadr-Ameli, Iraj Firoozi, Mohammad Taghi Salehi Emran,
Mohammad Jafar Hashemi. Iran University. Tehran
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Dysplasia of the Atrioventricular Nodal Artery in
Patients with Mitral Valve Prolapse and Sudden
Cardiac Death
Allen P. Burke, Andrew Farb, Anita L. Tang, Ira Rabin, Renu Virmani. Armed Forces
Insrirute ofPathology, Washington, DC
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Late results of balloon pulmonary valvuloplasty (BPV) in adults are not well
known. That is, the results are either early or medium-term ones, or they con-
sist of limited cases. For this purpose we followed up 127 patients (pts,) after
successful BPV for a period of &--7 years. Of these pts, 86 were male and 41
female with an average age of 29.7 (16-54) years. Average pulmonary valve
gradient (PVG) was 108.4 + 40.3 (5&--240) mm HG before and 22.3 + 8.5
(80--50) mm HG immediately after BPV (P < 0.0001). Mild to moderate pul-
monary insufficiency was detected in 35 pts. All patients were followed-up
every six months by doppler echocardiographyfor a period of 61-86 months.
As they did not refer at the last months of follow up, 16 pts. were excluded
from the study. After this period, the average PVG in the remaining pts. was
20.5 + 10.4 (8-60) mm HG (P < 0.0001). Of these Pts" in 27 cases, the aver-
age PVG was less than its value just after BPV; in 29 cases it was the same
and in the remaining 10 cases, the average PVG increased to a value of 44.6
+ 10.6 mm HG. After this period of follow up, pulmonary insufficiency was
increased slightly in 4 pts. One Pt. showed moderate right ventricular dys-
function due to severe PI. Average PVG was increased mainly in those pts ..
who showed a PVG of more than 35 mm HG shortly after BPV Right ventric-
ular hypertrophy in ECG was resolved in 78 Pts. after this period of follow
up.
In conclusion, PBV in adults is an effective and safe procedure. Late results
of this procedure are as good as their immediate ones.
Patients with isolated mitral valve prolapse (MVP) without significant mitral
regurgitation are at a slightly increased risk of sudden cardiac death com-
pared to the normal population. The mechanism(s) of sudden cardiac death
in isolated MVP are uncertain. We studied gross hearts and histologic sec-
tions of the atrioventricular (AV) node in 21 patients with isolated MVP dying
suddenly without apparent cause other than MVP (Group 1, mean age 36 ±
8 years, mean heart weight 420 ± 89 grams). No patient in Group 1 had a his-
tory of or treatment for mitral regurgitation, and no left atrial dilatation was
present at autopsy. Sudden cardiac death MVP cases were compared to 15
control hearts from trauma victims without cardiac disease (Group 2, mean
age 30 ± 7 years, mean heart weight 350 ± 96 grams). Sections of the artery
to the AV node within the atrial septum (mean 7 levels in each group) were
stained for elastic tissue and proteoglycans. Dysplasia was defined as focal
deposition of proteoglycans within the media and partial disruption of the in-
ternal elastic lamina. The ratio of lumen area to arterial area was determined
by computerized planimetry at the level of greatest luminal narrowing and
measured (mean ± SEM) 0.33 ± 0.04 for Group 1 and 0.52 ± 0.04 for Group
2 (p = 0.0011; this ratio was independent of heart weight, age, or sex of pa-
tient by stepwise regression. Dysplasia of the AV nodal artery was present
in 9/21 (43%) hearts in Group 1 versus 1/15 (7%) hearts in group 2 (p < 0.021
We conclude that narrowing of the AV nodal artery and arterial dysplasia are
more prevalent in patients with MVP and sudden cardiac death than controls
and may represent a more generalized disorder of proteoglycan deposition.
The relationship between these findings and sudden cardiac death needs to
be further studied,
Alfredo Zuppiroli, Mary J. Roman, Richard B. Devereux, Mariane C. Spitzer,
Michael J. O'Grady. Cornell Medical College, New York, N. Y
Mild instances of mitral valve prolapse (MVP) have been suggested to repre-
sent variants of normal, whereas individuals with complicated forms of MVP
have a distinct medical condition. This hypothesis would predict different
phenotypic features and patterns of inheritance in relatives of index cases
with complicated or uncomplicated MVP. Accordingly, we performed clinical
and echocardiographic assessment of 16 MVP patients with and 76 without
moderate to severe mitral regurgitation (MR+ and MR- probands) and 60
and 256, respectively, first-degree relatives (MR+ and MR- relatives). MR+
probands were older (p = 0.01). more likely to be male (p = 0.002), were
more overweight (p = 0.004) and had higher systolic blood pressures (p =
0.05) and larger aortic roots (p = 0.034) after the effects of age and body
size were taken into account. MR+ and MR- relatives had similar preva-
lences (27 and 32%) and age distribution of MVP, but affected MR+ rela-
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